| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 25 |
| 1 | BUDESONIDE | 22 |
| 2 | ALBUTEROL SULFATE | 21 |
| 3 | MONTELUKAST | 21 |
| 4 | MONTELUKAST SODIUM | 21 |
| 5 | AMLODIPINE | 20 |
| 6 | RISEDRONATE SODIUM | 16 |
| 7 | CALCIUM | 14 |
| 8 | CETIRIZINE HYDROCHLORIDE | 14 |
| 9 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEDAZURIDINE AND DECITABINE | 4 | 0.0041 |
| 1 | CROTAMITON | 1 | 0.0016 |
| 2 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 3 | DORAVIRINE | 1 | 0.0013 |
| 4 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 5 | NADOLOL | 7 | 0.0009 |
| 6 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 7 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 8 | FOSNETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| 9 | NETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 44 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 2 | Calcium Channel Blocker [EPC] | 20 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 20 |
| 4 | Calcium [EPC] | 14 |
| 5 | Integrin Receptor Antagonist [EPC] | 11 |
| 6 | beta-Adrenergic Blocker [EPC] | 9 |
| 7 | Provitamin D2 Compound [EPC] | 8 |
| 8 | Prostaglandin Analog [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 4 | Leukotriene Receptor Antagonist [EPC] | 4 | 0.0001 |
| 5 | Integrin Receptor Antagonist [EPC] | 11 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Glinide [EPC] | 1 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Calcium [EPC] | 14 | 0.0001 |